These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 8958799

  • 1. Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo.
    Sheu LF, Chen A, Meng CL, Ho KC, Lee WH, Leu FJ, Chao CF.
    J Pathol; 1996 Nov; 180(3):243-8. PubMed ID: 8958799
    [Abstract] [Full Text] [Related]

  • 2. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
    Li X, Liu X, Li CY, Ding Y, Chau D, Li G, Kung HF, Lin MC, Peng Y.
    Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
    [Abstract] [Full Text] [Related]

  • 3. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y, Sheen TS, Lu J, Huang YT, Chen JY, Yang CS, Tsai CH.
    Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis.
    Sheu LF, Chen A, Wei YH, Ho KC, Cheng JY, Meng CL, Lee WH.
    Am J Pathol; 1998 Jan; 152(1):63-74. PubMed ID: 9422524
    [Abstract] [Full Text] [Related]

  • 5. [Latency of Epstein-Barr virus and its relationship to nasopharyngeal carcinomas].
    You S, Yao K, Cao Y.
    Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):23-6. PubMed ID: 8732106
    [Abstract] [Full Text] [Related]

  • 6. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP, Hsu CL, Chang YL, Tsang NM, Chen CK, Lee TJ, Tsao KC, Huang CG, Chang YS, Yu JS, Hao SP.
    Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
    [Abstract] [Full Text] [Related]

  • 7. Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid diseases.
    Nicholls J, Kremmer E, Meseda CA, Mackett M, Hahn P, Gulley ML, Brink A, Swinnen LJ, Greenspan J, De Souza Y, Grässer F, Sham J, Ng MH, Arrand JR.
    J Med Virol; 2001 Sep; 65(1):105-13. PubMed ID: 11505451
    [Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus in nontumorigenic and tumorigenic nasopharyngeal carcinoma (NPC) somatic cell hybrids.
    Staczek J, Steplewski Z, Weinmann R, Klein G, Koprowski H.
    J Cell Physiol; 1981 Jun; 107(3):391-8. PubMed ID: 6265479
    [Abstract] [Full Text] [Related]

  • 9. [Effect of rAAV-mediated RNA interference against EB virus-encoded latent membrane protein 1 on nasopharyngeal carcinoma cell proliferation and metastasis in nude mice].
    Liu X, Liu X, Li G, Zhang B, Wang L, Li XH, Li XP.
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):611-4. PubMed ID: 19403376
    [Abstract] [Full Text] [Related]

  • 10. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
    Ho CH, Chen CL, Li WY, Chen CJ.
    Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
    [Abstract] [Full Text] [Related]

  • 11. Tumorigenicity of nasopharyngeal carcinoma hybrid cell line.
    Takimoto T, Ogura H, Ohno S, Umeda R, Hatano M.
    J Natl Cancer Inst; 1984 Sep; 73(3):711-5. PubMed ID: 6088881
    [Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q, Sato H, Murono S, Furukawa M, Yoshizaki T.
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [Abstract] [Full Text] [Related]

  • 13. Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma.
    Yoshizaki T, Endo K, Ren Q, Wakisaka N, Murono S, Kondo S, Sato H, Furukawa M.
    Auris Nasus Larynx; 2007 Mar; 34(1):73-8. PubMed ID: 17129696
    [Abstract] [Full Text] [Related]

  • 14. Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma.
    Heussinger N, Büttner M, Ott G, Brachtel E, Pilch BZ, Kremmer E, Niedobitek G.
    J Pathol; 2004 Jun; 203(2):696-9. PubMed ID: 15141385
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma.
    Liu JP, Cassar L, Pinto A, Li H.
    Cell Res; 2006 Oct; 16(10):809-17. PubMed ID: 17016469
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
    Wang L, Shan L, Lo KW, Yin J, Zhang Y, Sun R, Zhong J.
    J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
    [Abstract] [Full Text] [Related]

  • 17. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
    Paramita DK, Fachiroh J, Artama WT, van Benthem E, Haryana SM, Middeldorp JM.
    J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
    [Abstract] [Full Text] [Related]

  • 18. [The expression of HLA, Epstein-Barr virus nuclear antigen and the infiltration of T lymphocyte subsets in nasopharyngeal biopsy tissues].
    Chen X, Cai Y, Sun N.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994 Nov; 29(1):6-9. PubMed ID: 8031607
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus gene expression in nasopharyngeal carcinoma.
    Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson AB.
    J Gen Virol; 1988 May; 69 ( Pt 5)():1051-65. PubMed ID: 2836550
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.